Detalles de la búsqueda
1.
Safety and immunogenicity of a mosquito saliva peptide-based vaccine: a randomised, placebo-controlled, double-blind, phase 1 trial.
Lancet
; 395(10242): 1998-2007, 2020 06 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32534628
2.
Immunogenicity, Safety, and Efficacy of a Standalone Universal Influenza Vaccine, FLU-v, in Healthy Adults: A Randomized Clinical Trial.
Ann Intern Med
; 172(7): 453-462, 2020 04 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32150750
3.
Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial.
BMC Infect Dis
; 17(1): 241, 2017 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28376743
4.
Synthetic immunotherapy induces HIV virus specific Th1 cytotoxic response and death of an HIV-1 infected human cell line through classic complement activation.
Virol J
; 10: 107, 2013 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-23557359
5.
FLU-v, a Broad-Spectrum Influenza Vaccine, Induces Cross-Reactive Cellular Immune Responses in Humans Measured by Dual IFN-γ and Granzyme B ELISpot Assay.
Vaccines (Basel)
; 10(9)2022 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36146606
6.
Safety and immunogenicity of AGS-v PLUS, a mosquito saliva peptide vaccine against arboviral diseases: A randomized, double-blind, placebo-controlled Phase 1 trial.
EBioMedicine
; 86: 104375, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36436281
7.
Efficacy of FLU-v, a broad-spectrum influenza vaccine, in a randomized phase IIb human influenza challenge study.
NPJ Vaccines
; 5(1): 22, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32194999
8.
Meta-Analysis and Potential Role of Preexisting Heterosubtypic Cellular Immunity Based on Variations in Disease Severity Outcomes for Influenza Live Viral Challenges in Humans.
Clin Vaccine Immunol
; 22(8): 949-56, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26084515
9.
A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans.
Clin Vaccine Immunol
; 22(7): 828-35, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25994549
10.
Adrenomedullin signals through NF-kappaB in epithelial cells.
FEBS Lett
; 577(1-2): 249-54, 2004 Nov 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-15527794
11.
Safety, immunogenicity and efficacy assessment of HIV immunotherapy in a multi-centre, double-blind, randomised, Placebo-controlled Phase Ib human trial.
Vaccine
; 31(48): 5680-6, 2013 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-24120550
12.
Synthetic Influenza vaccine (FLU-v) stimulates cell mediated immunity in a double-blind, randomised, placebo-controlled Phase I trial.
Vaccine
; 30(31): 4655-60, 2012 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-22575166
13.
Identification of a novel cathelicidin gene in the rainbow trout, Oncorhynchus mykiss.
Infect Immun
; 73(8): 5053-64, 2005 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16041021
Resultados
1 -
13
de 13
1
Próxima >
>>